(S (NP (PRP We)) (VP (VBP develop) (NP (NP (ADJP (NP (DT a) (NN prediction)) (HYPH -) (VBN based)) (JJ prescriptive) (NN model)) (PP (IN for) (S (VP (VBG learning) (NP (JJ optimal) (VBN personalized) (NNS treatments)) (PP (IN for) (NP (NP (NNS patients)) (PP (VBN based) (PP (IN on) (NP (PRP$ their) (NML (NNP Electronic) (NNP Health)) (NNPS Records)))))))))) (PRN (-LRB- -LRB-) (NP (NNS EHRs)) (-RRB- -RRB-))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBZ consists) (PP (IN of)) (: :) (S (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (VP (VBG predicting) (NP (JJ future) (NNS outcomes)) (PP (IN under) (NP (NP (DT each) (JJ possible) (NN therapy)) (VP (VBG using) (NP (DT a) (VBN robustified) (JJ nonlinear) (NN model))))))) (, ,) (CC and) (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (VP (VBG adopting) (NP (NP (DT a) (JJ randomized) (JJ prescriptive) (NN policy)) (VP (VBN determined) (PP (IN by) (NP (DT the) (VBN predicted) (NNS outcomes))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (NP (NP (JJ theoretical) (NNS results)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP guarantee) (NP (NP (DT the) (NML (NML (NN out)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN sample)))) (JJ predictive) (NN power)) (PP (IN of) (NP (DT the) (NN model))))) (, ,) (CC and) (VP (VB prove) (NP (NP (DT the) (NN optimality)) (PP (IN of) (NP (DT the) (JJ randomized) (NN strategy)))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (DT the) (VBN expected) (JJ true) (JJ future) (NN outcome))))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP apply) (NP (DT the) (VBN proposed) (NN methodology) (S (VP (TO to) (VP (VB develop) (NP (JJ optimal) (NNS therapies)) (PP (IN for) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NML (NN type) (CD 2)) (NN diabetes)))) (CC or) (NP (NP (NP (NN hypertension)) (VP (VBG using) (NP (NNS EHRs)) (PP (IN from) (NP (DT a) (JJ major) (NN safety))))) (: -) (NP (NP (JJ net) (NN hospital)) (PP (IN in) (NP (NNP New) (NNP England)))))))))))) (, ,) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN algorithm)) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (JJR larger) (NN reduction)) (PP (IN of) (NP (DT the) (NN HbA1c))))) (, ,) (PP (IN for) (NP (NP (NP (NNS diabetics)) (, ,) (CC or) (NP (JJ systolic) (NN blood) (NN pressure)) (, ,)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NN hypertension))))) (, ,) (PP (VBN compared) (PP (IN to) (NP (DT the) (NNS alternatives))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ outperforms) (NP (NP (DT the) (NN standard)) (PP (IN of) (NP (NN care)))) (PP (IN under) (NP (DT the) (VBN robustified) (JJ nonlinear) (JJ predictive) (NN model))))))) (. .))
